about
Chlamydia psittaci: update on an underestimated zoonotic agentPoly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope.T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Immunity and vaccines against sexually transmitted Chlamydia trachomatis infectionBioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.Proteomic identification of immunodominant chlamydial antigens in a mouse modelFormulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles.CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract.Chlamydia trachomatis-infected epithelial cells and fibroblasts retain the ability to express surface-presented major histocompatibility complex class I molecules.Towards a safe and effective chlamydial vaccine: lessons from the eyeSubunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.
P2860
Q26823750-24C1F571-31C8-4B59-AE54-756C77FD0838Q33993714-276853F7-470A-4AA5-8336-3C36EE484CEDQ34749353-64F70999-BE30-401C-B476-93662D35AE29Q35206861-6FDD0CE4-04F7-4A6E-874B-777042FEB763Q35536190-751EBA29-22A2-49E8-9D7D-9286E0A0C93BQ35679647-16C650AA-A09C-4D87-A521-E974DC24B452Q36619644-50AD0F21-0259-4D22-A43C-670F8FBD45FBQ36852020-CD201E11-1884-4402-A0D5-636440ABDE88Q36950621-65CA467D-7BC7-4837-AFC1-2C7A9DE3DB58Q37643904-38A84646-3860-41F2-96CC-A7EA999C1BD5Q37709748-88DEF206-9103-46BC-BAE2-1D13923109C4Q37837221-88ECC97B-3EC1-43D5-AE26-5D6859CEA13DQ38110546-0DD9A996-CC81-440B-B91E-C4C4AF9952EF
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of a Chlamydia trachomatis T cell Vaccine.
@ast
Development of a Chlamydia trachomatis T cell Vaccine.
@en
Development of a Chlamydia trachomatis T cell Vaccine.
@nl
type
label
Development of a Chlamydia trachomatis T cell Vaccine.
@ast
Development of a Chlamydia trachomatis T cell Vaccine.
@en
Development of a Chlamydia trachomatis T cell Vaccine.
@nl
prefLabel
Development of a Chlamydia trachomatis T cell Vaccine.
@ast
Development of a Chlamydia trachomatis T cell Vaccine.
@en
Development of a Chlamydia trachomatis T cell Vaccine.
@nl
P2093
P2860
P356
P1433
P1476
Development of a Chlamydia trachomatis T cell Vaccine.
@en
P2093
Karuna P Karunakaran
Leonard J Foster
Robert C Brunham
P2860
P304
P356
10.4161/HV.6.8.12299
P577
2010-08-01T00:00:00Z